Related Experiment Video

Updated: May 5, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.1K

Clinical trials in children

Pathma D Joseph1, Jonathan C Craig, Patrina H Y Caldwell

  • 1The Discipline of Paediatrics and Child Health, The Children's Hospital at Westmead, The University of Sydney, Westmead, NSW, Australia.

British Journal of Clinical Pharmacology
|December 12, 2013
PubMed

Insights

Pediatric clinical trials are crucial for ensuring children receive safe and effective medicines. More research is needed to address challenges and improve access to evidence-based therapies for children.

Area of Science:

  • Pediatric pharmacology and clinical trial methodology.
  • Evidence-based medicine and drug safety in children.

Background:

  • Significant scarcity of safety and efficacy data for medications used in pediatric populations.
  • Risk of administering ineffective or potentially harmful drugs to children due to data gaps.
  • Delayed or non-utilization of beneficial therapies in children stemming from insufficient evidence.

Purpose of the Study:

  • To highlight the critical need for enhanced and relevant clinical trials in children.
  • To underscore the importance of improving knowledge regarding medication effects in pediatric patients.
  • To advocate for accelerated equitable access to evidence-based therapies for children.

Main Methods:

  • Discussion of the role of clinical trials in generating reliable evidence for treatment effects.
  • Analysis of the challenges specific to conducting pediatric trials, including funding, ethical considerations, and pediatric uniqueness.
  • Review of current regulations and initiatives aimed at improving pediatric clinical trials.

Main Results:

  • Current pediatric trial landscape shows improvements in scope, quantity, and quality due to regulations and initiatives.
  • Despite progress, significant deficiencies persist in pediatric clinical research.
  • These deficiencies hinder the acceleration of equitable access to evidence-based pediatric therapies.

Conclusions:

  • There is an urgent need for more robust and targeted clinical trials in the pediatric population.
  • Addressing the unique challenges of pediatric research is essential for advancing child health.
  • Further efforts are required to overcome existing barriers and ensure all children benefit from proven medical treatments.

Keywords:
clinical trialsethicsmedicines in childrenpaediatric drug therapy

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

17.5K
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

928

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K